{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:17Z","timestamp":1789142477676,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["UID\/Multi\/00709\/2019"],"award-info":[{"award-number":["UID\/Multi\/00709\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/148028\/2019"],"award-info":[{"award-number":["SFRH\/BD\/148028\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"POCI-COMPETE 2020-Operational Programme Competitiveness and Internationalization","award":["007491"],"award-info":[{"award-number":["007491"]}]},{"name":"C4-Cloud Computing Competences Center","award":["CENTRO-01-0145-FEDER-000019"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-000019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Xanthine oxidase (XO) is the enzyme responsible for the conversion of endogenous purines into uric acid. Therefore, this enzyme has been associated with pathological conditions caused by hyperuricemia, such as the disease commonly known as gout. Barbiturates and their congeners thiobarbiturates represent a class of heterocyclic drugs capable of influencing neurotransmission. However, in recent years a very large group of potential pharmaceutical and medicinal applications have been related to their structure. This great diversity of biological activities is directly linked to the enormous opportunities found for chemical change off the back of these findings. With this in mind, sixteen bis-thiobarbiturates were synthesized in moderate to excellent reactional yields, and their antioxidant, anti-proliferative, and XO inhibitory activity were evaluated. In general, all bis-thiobarbiturates present a good antioxidant performance and an excellent ability to inhibit XO at a concentration of 30 \u00b5M, eight of them are superior to those observed with the reference drug allopurinol (Allo), nevertheless they were not as effective as febuxostat. The most powerful bis-thiobarbiturate within this set showed in vitro IC50 of 1.79 \u03bcM, which was about ten-fold better than Allo inhibition, together with suitable low cytotoxicity. In silico molecular properties such as drug-likeness, pharmacokinetics, and toxicity of this promising barbiturate were also analyzed and herein discussed.<\/jats:p>","DOI":"10.3390\/biomedicines9101443","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:16:42Z","timestamp":1633943802000},"page":"1443","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bis-thiobarbiturates as Promising Xanthine Oxidase Inhibitors: Synthesis and Biological Evaluation"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-7976","authenticated-orcid":false,"given":"Jo\u00e3o L.","family":"Serrano","sequence":"first","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-6360","authenticated-orcid":false,"given":"Diana","family":"Lopes","sequence":"additional","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani J. A.","family":"Reis","sequence":"additional","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-2622","authenticated-orcid":false,"given":"Renato E. F.","family":"Boto","sequence":"additional","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-5108","authenticated-orcid":false,"given":"Samuel","family":"Silvestre","sequence":"additional","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"},{"name":"CNC\u2014Center for Neuroscience and Cell Biology, University of Coimbra, Rua Larga, 3004-517 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0110-4795","authenticated-orcid":false,"given":"Paulo","family":"Almeida","sequence":"additional","affiliation":[{"name":"CICS-UBI\u2014Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilh\u00e3, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2017.04.031","article-title":"Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity","volume":"135","author":"Jakopin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/np970237h","article-title":"Structure\u2212activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers","volume":"61","author":"Cos","year":"1998","journal-title":"J. Nat. Prod."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3527579","DOI":"10.1155\/2016\/3527579","article-title":"Xanthine oxidoreductase-derived reactive species: Physiological and pathological effects","volume":"2016","author":"Battelli","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2013","journal-title":"Curr. Rheumat. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fmed.2018.00160","article-title":"Physiology of hyperuricemia and urate-lowering treatments","volume":"5","author":"Benn","year":"2018","journal-title":"Front. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9531725","DOI":"10.1155\/2020\/9531725","article-title":"From xanthine oxidase inhibition to in vivo hypouricemic effect: An integrated overview of in vitro and in vivo studies with focus on natural molecules and analogues","volume":"2020","author":"Serrano","year":"2020","journal-title":"Evid-Based. Complement. Alternat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/13543776.2020.1811233","article-title":"Xanthine oxidase inhibitors: Patent landscape and clinical development (2015\u20132020)","volume":"30","author":"Singh","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kerru, N., Gummidi, L., Maddila, S., Gangu, K.K., and Jonnalagadda, S.B. (2020). A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules, 25.","DOI":"10.3390\/molecules25081909"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1385272824666200110094457","article-title":"A comprehensive review: Bio-potential of barbituric acid and its analogues","volume":"24","author":"Nusrat","year":"2020","journal-title":"Curr. Org. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ddr.21761","article-title":"Barbiturate derivatives for managing multifaceted oncogenic pathways: A mini review","volume":"82","author":"Prasher","year":"2021","journal-title":"Drug Develop. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00044-017-2126-0","article-title":"Thiobarbiturates as potential antifungal agents to control human infections caused by Candida and Cryptococcus species","volume":"27","author":"Shabeer","year":"2018","journal-title":"Med. Chem. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejmech.2017.11.070","article-title":"Trisubstituted barbiturates and thiobarbiturates: Synthesis and biological evaluation as xanthine oxidase inhibitors, antioxidants, antibacterial and anti-proliferative agents","volume":"143","author":"Figueiredo","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104964","DOI":"10.1016\/j.ejps.2019.104964","article-title":"5-Hydrazinylethylidenepyrimidines effective against multidrug-resistant Acinetobacter baumannii: Synthesis and in vitro biological evaluation of antibacterial, radical scavenging and cytotoxic activities","volume":"137","author":"Figueiredo","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/cmdc.201800414","article-title":"Exploiting the thiobarbituric acid scaffold for antibacterial activity","volume":"13","author":"Sharma","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/acs.jmedchem.7b01388","article-title":"Pharmacophore hybridization to discover novel topoisomerase II poisons with promising antiproliferative activity","volume":"61","author":"Ortega","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1002\/slct.201800832","article-title":"Design, synthesis and anticancer evaluation of oxa\/thiadiazolylhydrazones of barbituric and thiobarbituric acid: A collective in vitro and in silico approach","volume":"3","author":"Bhatt","year":"2018","journal-title":"ChemistrySelect"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cagno, V., Tintori, C., Civra, A., Cavalli, R., Tiberi, M., Botta, L., Brai, A., Poli, G., Tapparel, C., and Lembo, D. (2018). Novel broad spectrum virucidal molecules against enveloped viruses. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0208333"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/j.bmc.2015.05.038","article-title":"Design and synthesis of new barbituric- and thiobarbituric acid derivatives as potent urease inhibitors: Structure activity relationship and molecular modeling studies","volume":"23","author":"Rauf","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bmcl.2018.12.026","article-title":"N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3","volume":"29","author":"Marecki","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1039\/a904015c","article-title":"Reactions of 1,3-diethyl-2-thiobarbituric acid with aldehydes: Formation of arylbis(1,3-diethyl-2-thiobarbitur-5-yl)methanes \u2020 and crystallographic evidence for ground state polarisation in 1,3-diethyl-5-[4-(dimethylamino)benzylidene]-2-thiobarbituric acid","volume":"1","author":"Adamson","year":"1999","journal-title":"J. Chem. Soc. Perkin Trans. I"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cclet.2015.12.035","article-title":"Development of bis-thiobarbiturates as successful urease inhibitors and their molecular modeling studies","volume":"27","author":"Rahim","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1139\/V10-015","article-title":"A novel approach towards the synthesis of tricyclic systems based on pyridine, pyran, thiopyran, azepine, oxepin, thiepin, and pyrimidine rings under different solvent conditions","volume":"88","author":"Sachar","year":"2010","journal-title":"Can. J. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"84943","DOI":"10.1039\/C6RA14596E","article-title":"Potential antitumoral 3,4-dihydropyrimidin-2-(1H)-ones: Synthesis, in vitro biological evaluation and QSAR studies","volume":"6","author":"Matias","year":"2016","journal-title":"RSC Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jhet.5570400310","article-title":"Preparation of 5,5\u2032-pyrilidene and 5,5\u2032-quinolidene bis-barbituric acid derivatives","volume":"40","author":"Jursic","year":"2003","journal-title":"J. Het. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101070","DOI":"10.1016\/j.redox.2018.101070","article-title":"Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase","volume":"21","author":"Battelli","year":"2019","journal-title":"Redox Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cam4.601","article-title":"Xanthine oxidoreductase in cancer: More than a differentiation marker","volume":"5","author":"Battelli","year":"2016","journal-title":"Cancer Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"104620","DOI":"10.1016\/j.bioorg.2020.104620","article-title":"Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition","volume":"107","author":"Joshi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fchem.2020.00612","article-title":"Editorial: In silico methods for drug design and discovery","volume":"8","author":"Brogi","year":"2020","journal-title":"Front. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/bib\/bby061","article-title":"Recent applications of deep learning and machine intelligence on in silico drug discovery: Methods, tools and databases","volume":"20","author":"Rifaioglu","year":"2019","journal-title":"Brief. Bioinform."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cpt.1360","article-title":"Clinical aspects of transporter-mediated drug\u2013drug interactions","volume":"105","author":"Gessner","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: A review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug Targets"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1443\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:11:35Z","timestamp":1760166695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/10\/1443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["biomedicines9101443"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9101443","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}